Advancement of clinical therapeutic research on glioma: A narrative review

As theories evolve, the mechanism of glioma origination remains poorly understood. Understanding this mechanism promotes the clinical research on glioma therapeutic strategy and then improves the prognosis of patients with glioma. However, the overall survival of these patients is unsatisfactory. In...

Full description

Bibliographic Details
Main Authors: Fengping Li, Chao Ma, Chengshi Xu, Zhiyong Pan, Zhiqiang Li
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Glioma
Subjects:
Online Access:http://www.jglioma.com/article.asp?issn=2589-6113;year=2020;volume=3;issue=3;spage=119;epage=125;aulast=
Description
Summary:As theories evolve, the mechanism of glioma origination remains poorly understood. Understanding this mechanism promotes the clinical research on glioma therapeutic strategy and then improves the prognosis of patients with glioma. However, the overall survival of these patients is unsatisfactory. In the recent decade, a few novel therapies, such as tumor-treating fields and immunotherapy, have been introduced in clinic. Before they can be widely used, many key factors, including efficacy, safety, and benefit ratio, should be fully evaluated. Therefore, more clinical trials are required to corroborate the results and conclusions of basic research and improve the current treatment strategies. In this article, we searched relevant literature published in the past 5 years in PubMed and China National Knowledge Infrastructure and reviewed the advancements of clinical therapeutic research on glioma.
ISSN:2589-6113
2589-6121